IMR Press / EJGO / Volume 38 / Issue 3 / DOI: 10.12892/ejgo3482.2017

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Long-term remission of clear cell carcinoma of the cervix after chemoradiation with 109 cycles of paclitaxel: a case report and literature review
Show Less
1 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics and Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Eur. J. Gynaecol. Oncol. 2017, 38(3), 456–458; https://doi.org/10.12892/ejgo3482.2017
Published: 10 June 2017
Abstract

Background: Clear cell carcinoma of cervix (CCCC) is a rare cervical neoplasm that is usually associated with diethylstilbestrol (DES) exposure in utero as a primary risk factor. Advanced stage disease typically has poor outcomes and no evidence-based approach exists to guide clinicians in treating this rare disease. Case: The authors report a case of locally advanced CCCC in a 37-year-old Caucasian female. She underwent chemoradiation therapy that included 109 courses of paclitaxel chemotherapy until no disease could be detected on imaging studies. She is now disease-free 13 years after discontinuing chemotherapy. Conclusion: A prolonged course of single agent paclitaxel after completing standard radiation therapy was successful in achieving remission in a patient with this rare disease.
Keywords
Clear cell carcinoma of the cervix
Paclitaxel
Chemotherapy
Share
Back to top